Ischemic stroke risk estimation in patients without oral anticoagulation: an observational cohort study based on secondary data from Germany
Abstract Background Oral anticoagulants can cause potentially serious adverse events. Therefore, before prescribing oral anticoagulants for ischemic stroke prevention in patients with atrial fibrillation (AF), stroke risk assessment is required to identify patients that are likely to benefit from tr...
Main Authors: | Felix S. Wicke, Martin A. Schaller, Kateryna Karymova, Martin Beyer, Beate S. Müller |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-04-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12872-019-1074-7 |
Similar Items
-
The CHA2DS2-VASc Score Predicts Major Bleeding in Non-Valvular Atrial Fibrillation Patients Who Take Oral Anticoagulants
by: Kuang-Tso Lee, et al.
Published: (2018-10-01) -
Atrial fibrillation and CHA2DS2VASc score of 1 - is there a problem in clinical practice?
by: E. I. Baranova, et al.
Published: (2020-04-01) -
Assessment of the compatibility of the real-world nonvalvular atrial fibrillation patients in Turkey with the study population of Phase 3 novel oral anticoagulant trials: An auxiliary study of NOAC-TR
by: Sadik Volkan Emren, et al.
Published: (2020-01-01) -
Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study
by: Ting Liu, et al.
Published: (2020-01-01) -
Sex-gender and atrial fibrillation treatment in the AntiThrombotic Agents in Atrial Fibrillation (ATA-AF) study
by: Cecilia Politi, et al.
Published: (2016-02-01)